Item 8.01. Other Events.

On January 6, 2022, Kinnate Biopharma Inc. issued a press release announcing a corporate update, expected milestones for 2022 and its cash, cash equivalents and investments balance as of December 31, 2021. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits.



   Exhibit No.   Description

     99.1        Press Release dated January 6, 2022.

   104           Cover page interactive date file (embedded within the inline XBRL
                 document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses